| pubmed-article:19687340 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19687340 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19687340 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:19687340 | lifeskim:mentions | umls-concept:C0280100 | lld:lifeskim |
| pubmed-article:19687340 | lifeskim:mentions | umls-concept:C0123931 | lld:lifeskim |
| pubmed-article:19687340 | lifeskim:mentions | umls-concept:C0005508 | lld:lifeskim |
| pubmed-article:19687340 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
| pubmed-article:19687340 | lifeskim:mentions | umls-concept:C1268567 | lld:lifeskim |
| pubmed-article:19687340 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
| pubmed-article:19687340 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
| pubmed-article:19687340 | pubmed:issue | 27 | lld:pubmed |
| pubmed-article:19687340 | pubmed:dateCreated | 2009-10-2 | lld:pubmed |
| pubmed-article:19687340 | pubmed:abstractText | To assess the maximum-tolerated dosages (MTDs), and dose-limiting toxicities (DLTs) of the epidermal growth factor receptor inhibitor gefitinib and of intravenous (IV) irinotecan when administered together in children with refractory solid tumors. To assess the effect of gefitinib on the pharmacokinetics of IV irinotecan and on the bioavailability of a single oral dose of irinotecan. | lld:pubmed |
| pubmed-article:19687340 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19687340 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19687340 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19687340 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19687340 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19687340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19687340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19687340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19687340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19687340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19687340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19687340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19687340 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19687340 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19687340 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:19687340 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:HoughtonPeter... | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:Rodriguez-Gal... | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:SpuntSheri... | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:DawNajat CNC | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:FurmanWayne... | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:StewartClinto... | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:SantanaVictor... | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:WuJianrongJ | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:CrewsKristine... | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:McCarvilleM... | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:NavidFaribaF | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:GajjarAmar... | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:PanettaJohn... | lld:pubmed |
| pubmed-article:19687340 | pubmed:author | pubmed-author:McGregorLisa... | lld:pubmed |
| pubmed-article:19687340 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19687340 | pubmed:day | 20 | lld:pubmed |
| pubmed-article:19687340 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:19687340 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19687340 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19687340 | pubmed:pagination | 4599-604 | lld:pubmed |
| pubmed-article:19687340 | pubmed:dateRevised | 2010-9-21 | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:meshHeading | pubmed-meshheading:19687340... | lld:pubmed |
| pubmed-article:19687340 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19687340 | pubmed:articleTitle | Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors. | lld:pubmed |
| pubmed-article:19687340 | pubmed:affiliation | Department of Oncology, St Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105-3678, USA. wayne.furman@stjude.org | lld:pubmed |
| pubmed-article:19687340 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19687340 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19687340 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| pubmed-article:19687340 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19687340 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19687340 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19687340 | lld:pubmed |
